scorecardresearch

Friday, November 20, 2026

Support our Journalism

Depth, context and analysis

Subscribe
HomeIndiaOver 2,200 drug manufactured in Himachal failed quality tests in past three...

Over 2,200 drug manufactured in Himachal failed quality tests in past three years: Minister

Stay updated with ThePrint:

Shimla/Dharamshala (HP), Nov 20 (PTI) As many as 2,216 pharmaceutical drugs manufactured in Himachal Pradesh failed to meet quality standards in the past three years, Health and Family Welfare Minister Colonel Dhani Ram Shandil informed the assembly on Friday.

In a written response to a question by Bharmaur BJP MLA Dr Janak Raj, the minister further said licenses of three drug-manufacturing firms have been cancelled due to repeated failure to meet established quality criteria.

Further, as many as 1,608 product licenses have been suspended and 59 licenses have been cancelled. In four instances, the manufacturer has been issued warnings.

According to the government, these measures have led to either halt in the manufacturing of 1,667 products or the cancellation of their respective licenses.

The minister said instructions have been issued to recall all drugs that failed to meet quality standards from the market, while the state’s drug control department has initiated legal action in 17 such cases.

According to the government, 47 pharmaceutical companies have been identified whose product samples failed quality tests ten or more times over the past few years.

The drug control department and the Central Drugs Standard Control Organization (CDSCO) have taken action to investigate these companies.

Joint inspections of 43 of these 47 companies were conducted by the department in coordination with the CDSCO. Additionally, these companies were also inspected separately by the state drug controller.

The minister said following the inspections, the licenses of three of the 43 companies were completely revoked. Meanwhile, drug manufacturing has been either fully or partially suspended in 19 companies.

This suspension will remain in effect until the respective companies ensure compliance with the provisions of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945.

To ensure medicine quality and establish accountability for manufacturing units, the government has directed drug inspectors to inspect every drug manufacturing unit at least once a year.

MLA Dr Janak Raj had sought details from the government regarding medicines that failed quality tests over the last three years, the actions taken against the companies involved, and the measures implemented to ensure the accountability of responsible companies and officials. PTI BPL ARB

ARB

This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

For readers who want the full picture.

You read our articles closely. Subscribe to go further, with exclusive newsletters in your inbox, flagship events hosted by Shekhar Gupta, AMAs with our senior editors, the chance to write under your own byline, and more.

Subscribe to ThePrint →
  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular